Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bean

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Transplantation Direct|May 31, 2021
A Mixed-chimerism Protocol Utilizing Thymoglobulin and Belatacept Did Not Induce Lung Allograft Tolerance, Despite Previous Success in Renal AllotransplantationWiebke Sommer, Jane M O, Kurt B Pruner, et al.
Journal of Medicinal Chemistry|November 14, 2003
Design and synthesis of a potent and selective triazolone-based peroxisome proliferator-activated receptor alpha agonistYanping Xu, Daniel Mayhugh, Ashraf Saeed, et al.
Diabetes|March 28, 2002
A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-alpha/gamma agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical modelsGarret J Etgen, Brian A Oldham, William T Johnson, et al.
Journal of Medicinal Chemistry|April 30, 2004
Design and synthesis of alpha-aryloxy-alpha-methylhydrocinnamic acids: a novel class of dual peroxisome proliferator-activated receptor alpha/gamma agonistsYanping Xu, Christopher J Rito, Garret J Etgen, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Transplantation Direct|May 31, 2021
A Mixed-chimerism Protocol Utilizing Thymoglobulin and Belatacept Did Not Induce Lung Allograft Tolerance, Despite Previous Success in Renal AllotransplantationWiebke Sommer, Jane M O, Kurt B Pruner, et al.
Journal of Medicinal Chemistry|November 14, 2003
Design and synthesis of a potent and selective triazolone-based peroxisome proliferator-activated receptor alpha agonistYanping Xu, Daniel Mayhugh, Ashraf Saeed, et al.
Diabetes|March 28, 2002
A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-alpha/gamma agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical modelsGarret J Etgen, Brian A Oldham, William T Johnson, et al.
Journal of Medicinal Chemistry|April 30, 2004
Design and synthesis of alpha-aryloxy-alpha-methylhydrocinnamic acids: a novel class of dual peroxisome proliferator-activated receptor alpha/gamma agonistsYanping Xu, Christopher J Rito, Garret J Etgen, et al.
Pageof 6